Finance

Lists
EMBC:NASDAQ
Embecta Corp
$5.29
+1.93%
(+0.100) 1D
$5.26
-0.57% (-0.030)
After hours
Closed: Sep 18, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EMBC...
Open
$5.13
High
$5.30
Low
$5.09
Mkt. cap
299.73M
Avg. vol.
1.60M
Volume
3.52M
Dividend
0.76%
Quarterly dividend
$0.01
Ex-dividend date
Aug 27, 2026
P/E ratio
3.58
52-wk high
$15.17
52-wk low
$2.77
EPS
$1.48
Beta
0.85
Shares outstanding
56.66M
No. of employees
2K
Open
$5.13
High
$5.30
Low
$5.09
Mkt. cap
299.73M
Avg. vol.
1.60M
Volume
3.52M
Dividend
0.76%
Quarterly dividend
$0.01
Ex-dividend date
Aug 27, 2026
P/E ratio
3.58
52-wk high
$15.17
52-wk low
$2.77
EPS
$1.48
Beta
0.85
Shares outstanding
56.66M
No. of employees
2K
News stories
From web sources and news partners
About Embecta Corp
CEO-
Employees1.85K
Founded1924
HeadquartersParsippany-Troy Hills, New Jersey, United States
SectorMedical device
Websiteembecta.com
Analyst ratings
Based on 1 analyst giving stock ratings to EMBC in the past 3 months
Sell
Buy
0
Hold
0
Sell
1
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for EMBC in the last 3 months
Highest
Current $5.29
(-100.00%)
Average
(-100.00%)
Lowest
(-100.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Travis Steed
Bank of America Securities
Sell
Maintained
-
-
08/10/2026
Marie Thibault
BTIG
Hold
Maintained
-
-
06/15/2026
Anthony Petrone
Mizuho Securities
Hold
Maintained
$5.00
-5.5%
05/06/2026
Last report
Aug 7, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$0.56 / $0.26
+111.32%beat
Revenue / Est. (USD)
271.70M / 254.54M
+6.74%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
264.00M
261.20M
221.80M
271.70M
Cost of goods sold
105.40M
99.50M
94.00M
118.40M
Cost of revenue
105.40M
99.50M
94.00M
118.40M
Research and development expenses
4.60M
4.60M
5.40M
5.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
86.90M
77.60M
76.20M
78.60M
Operating expense
93.00M
85.40M
84.90M
89.00M
Total operating expenses
198.40M
184.90M
178.90M
207.40M
Operating income
65.60M
76.30M
42.90M
64.30M
Other non operating income
-2.60M
-300.00K
-2.90M
2.80M
EBT including unusual items
29.00M
58.90M
9.50M
27.60M
EBT excluding unusual items
38.10M
51.90M
17.40M
43.20M
Income tax expense
2.60M
14.80M
13.60M
6.50M
Effective tax rate
8.97%
25.13%
143.16%
23.55%
Other operating expenses
1.50M
3.20M
3.30M
4.80M
Net income
26.40M
44.10M
-4.10M
21.10M
Net profit margin
10.00%
16.88%
-1.85%
7.77%
Earnings per share
0.50
0.71
0.27
0.56
Interest and investment income
6.00M
900.00K
700.00K
800.00K
Interest expense
-32.10M
-25.00M
-23.30M
-24.70M
Net interest expenses
-26.10M
-24.10M
-22.60M
-23.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
78.70M
86.60M
53.10M
74.90M
Gain or loss from assets sale
-
-10.10M
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps